These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 22689516)

  • 21. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions.
    Nagano T; Seki N; Tomita Y; Sugita T; Aida Y; Itagaki M; Sutoh S; Abe H; Tsubota A; Aizawa Y
    Int J Mol Sci; 2015 Aug; 16(9):20576-94. PubMed ID: 26334270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
    Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
    J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids and HCV.
    Bassendine MF; Sheridan DA; Bridge SH; Felmlee DJ; Neely RD
    Semin Immunopathol; 2013 Jan; 35(1):87-100. PubMed ID: 23111699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
    Shimizu Y; Hishiki T; Sugiyama K; Ogawa K; Funami K; Kato A; Ohsaki Y; Fujimoto T; Takaku H; Shimotohno K
    Virology; 2010 Nov; 407(1):152-9. PubMed ID: 20822787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
    Goldberg IJ; Le NA; Ginsberg HN; Krauss RM; Lindgren FT
    J Clin Invest; 1988 Feb; 81(2):561-8. PubMed ID: 3276735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
    Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
    Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
    Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
    J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
    Wang CS; McConathy WJ; Kloer HU; Alaupovic P
    J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
    J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
    J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
    J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass.
    Milosavljevic D; Kontush A; Griglio S; Le Naour G; Thillet J; Chapman MJ
    Biochim Biophys Acta; 2003 Feb; 1631(1):51-60. PubMed ID: 12573449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.
    Kinoshita C; Nagano T; Seki N; Tomita Y; Sugita T; Aida Y; Itagaki M; Satoh K; Sutoh S; Abe H; Tsubota A; Aizawa Y
    World J Gastroenterol; 2016 Aug; 22(29):6716-25. PubMed ID: 27547014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
    Maillard P; Walic M; Meuleman P; Roohvand F; Huby T; Le Goff W; Leroux-Roels G; Pécheur EI; Budkowska A
    PLoS One; 2011; 6(10):e26637. PubMed ID: 22039521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.